Cure & Advancements/June 4, 2026/2 min read

Europe Launches Major Screening Initiative to Catch Type 1 Diabetes Early

A continent-wide project called EDENT1FI is testing hundreds of thousands of children for type 1 diabetes before symptoms appear, aiming to intervene early and improve outcomes.

News report — unverified, pending corroboration

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cure researchbeta cellsadvancements

Key takeaways

EDENT1FI has screened 100,000 people across Europe and plans to reach 220,000 by project completion
A simple blood test can detect type 1 diabetes long before symptoms develop
Early detection creates opportunities for timely intervention and better patient outcomes
The project is expanding screening programs to new countries while strengthening existing efforts

A Growing Need for Early Detection

Type 1 diabetes affects approximately 9 million people worldwide, including 300,000 children in Europe. Each year, about 31,000 new cases are diagnosed across the continent. As an autoimmune condition, type 1 diabetes occurs when the pancreas produces little or no insulin, requiring lifelong insulin therapy for survival.

While there is currently no cure for type 1 diabetes, researchers have discovered that the disease can be detected through a simple blood test years before symptoms appear. This window of opportunity has opened the door to new possibilities for early intervention and better health outcomes.

EDENT1FI: Screening Across Europe

The EU-funded EDENT1FI project launched in 2023 with an ambitious goal: bring general population screening for type 1 diabetes to Europe. Now halfway through its mission, the project has successfully screened 100,000 participants across multiple countries, with plans to reach another 120,000 by the end of the project.

EDENT1FI is building on previous successes, including the Fr1da study in Germany, which pioneered early-stage type 1 diabetes screening. The project has launched new screening programs in Czechia, Poland, and Portugal while strengthening existing initiatives in Denmark, Germany, Italy, Sweden, and the United Kingdom.

Why Early Detection Matters

Detecting type 1 diabetes before symptoms develop allows doctors and families to take action early. This timely intervention can improve patient outcomes and help children and adolescents manage their condition more effectively from the start.

By identifying those at risk or in early stages of the disease, EDENT1FI aims to prevent the severe onset of type 1 diabetes in over 200,000 children and adolescents across Europe.

Evidence label

Origin: CORDIS | European Commission (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.